Stem Cell-Free Therapy : Engineering Exosomes and Secretomes for Next-Generation Therapeutics
Language: English
Published by Taylor & Francis Ltd Sep 2026, 2026
- Hardcover
- New
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
AbeBooks seller since August 14, 2006
Condition: New
£ 212.93
Quantity: 2 available
Add to basketItem description from seller
Neuware - This book provides a comprehensive review of the advancements in cell-free therapeutic applications, focusing on the biological and biomedical potential of mesenchymal stem cell (MSC)-derived secretome and extracellular vesicles (EVs) in disease treatment and tissue repair. It examines the mechanistic functions of MSC-derived biomolecules and the regulatory landscape shaping their development. The discussion then progresses to innovative strategies for enhancing the MSC secretome through priming techniques, optimizing its biological activity for therapeutic applications. The book examines the application of exosome-based and EV-driven therapies across a broad range of biomedical fields, including neuroscience, cardiology, ophthalmology, gastroenterology, and oncology. Further, it highlights the role of MSC-derived secretome in treating neurocognitive disorders, autoimmune diseases, diabetes complications, and inflammatory conditions, with a special focus on innovations in drug delivery, tissue repair. Additionally, it examines the emerging use of EVs as theranostic tools in cancer therapy and their application in novel treatment strategies for COVID-19. The book also addresses key challenges in transitioning these cell-free therapies from bench to bedside, covering critical aspects such as formulation, large-scale production, regulatory approvals, and clinical implementation.Key Features: - Explores the biomedical applications of MSC-derived secretome and EVs across different diseases. - Discusses the biological and therapeutic potential of exosome-based treatments for neurodegenerative, cardiovascular, ophthalmological, and metabolic diseases. - Examines innovations in extracellular vesicle-based cell-free therapies for targeted tissue repair and disease intervention. - Reviews the challenges of translating EV-based therapeutics into clinical practice, including regulatory and manufacturing considerations. - Highlights cutting-edge applications of EVs in oncology, infectious diseases, and theranostics. This book serves as an important resource for researchers and students of biomedical engineering, biotechnology, and stem cell biology.…
Seller Inventory # 9781041101000
- Title
- Stem Cell-Free Therapy : Engineering Exosomes and Secretomes for Next-Generation Therapeutics
- Author
- Khawaja H. Haider
- Publisher
- Taylor & Francis Ltd Sep 2026
- Publication year
- 2026
- Condition
- Neu
- Binding
- Buch
- Language
- English
- ISBN 10
- 1041101007
- ISBN 13
- 9781041101000
- Item weight
- 1,460 grams
- Dimensions
- 254x178x38 mm
This book provides a comprehensive review of the advancements in cell-free therapeutic applications, focusing on the biological and biomedical potential of mesenchymal stem cell (MSC)-derived secretome and extracellular vesicles (EVs) in disease treatment and tissue repair. It examines the mechanistic functions of MSC-derived biomolecules and the regulatory landscape shaping their development. The discussion then progresses to innovative strategies for enhancing the MSC secretome through priming techniques, optimizing its biological activity for therapeutic applications. The book examines the application of exosome-based and EV-driven therapies across a broad range of biomedical fields, including neuroscience, cardiology, ophthalmology, gastroenterology, and oncology. Further, it highlights the role of MSC-derived secretome in treating neurocognitive disorders, autoimmune diseases, diabetes complications, and inflammatory conditions, with a special focus on innovations in drug delivery, tissue repair. Additionally, it examines the emerging use of EVs as theranostic tools in cancer therapy and their application in novel treatment strategies for COVID-19. The book also addresses key challenges in transitioning these cell-free therapies from bench to bedside, covering critical aspects such as formulation, large-scale production, regulatory approvals, and clinical implementation.
Key Features:
- Explores the biomedical applications of MSC-derived secretome and EVs across different diseases.
- Discusses the biological and therapeutic potential of exosome-based treatments for neurodegenerative, cardiovascular, ophthalmological, and metabolic diseases.
- Examines innovations in extracellular vesicle-based cell-free therapies for targeted tissue repair and disease intervention.
- Reviews the challenges of translating EV-based therapeutics into clinical practice, including regulatory and manufacturing considerations.
- Highlights cutting-edge applications of EVs in oncology, infectious diseases, and theranostics.
This book serves as an important resource for researchers and students of biomedical engineering, biotechnology, and stem cell biology.
"Synopsis" may belong to another edition of this title.
About the Author
Khawaja H. Haider is a Professor of Cellular and Molecular Pharmacology (Stem Cell and Gene Therapy) and Chairman of the Basic Sciences Department (Medical Program) at Sulaiman AlRajhi University, Saudi Arabia. Before his current assignment, he served in several prestigious institutions in various parts of the world. He has also served as Principal Investigator (PI) and Co-PI on multiple National Institute of Health (NIH) funded stem cell research projects. He has been on the editorial boards and invited reviewer panels for several respected international journals. His research focuses on using, either alone or in combination, DNA, miRNAs, and stem cells as “drugs,” a topic that has gained popularity in regenerative medicine. He has extensively published on cellular and sub-cellular preconditioning of stem cells and using their conditioned media for cell-free therapy. He has published nearly 350 book chapters, abstracts, and research papers in various books and leading research journals, including Circulation, Circulation Research, Cardiovascular Research, JCMM, the Journal of Biological Chemistry, Cell Cycle, Basic Research in Cardiology, and Antioxidant Redox Signaling. He has also given numerous presentations and edited ten books covering various facets of stem cells and their applications from drug to drug development.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 7 to 10 business days | 5 to 7 business days |
|---|---|---|
| First item | £ 38.33 | £ 52.99 |
Payment methods
- Bank Wire Transfer
- Check
- Paypal
Store description
Das Unternehmen AHA-BUCH GmbH: Seit der Gründung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisgünstig wie möglich ihren Bücherwunsch zu erfüllen. Unsere Firma beschäftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine Wünsche! Auf über 3700 m2 Fläche haben wir über 100.000 Bücher, Modernes Antiquariat und Spiele auf Lager.
Specialty
Kinderbücher & Kinderhör Casetten, German Books, Software, Natur & Tiere, Ratgeber, Sachbücher, Englische Bücher, Medizin & Gesundheit, Universität & StudiumSeller's business information
AHA-BUCH GmbH
Garlebsen 48
Einbeck, Germany 37574
Terms of sale
Imprint
Seller Info:
AHA-BUCH GmbH
represented by the managing director Christel Glass
Garlebsen 48
37574 Einbeck
Deutschland
Telefon: 055639996039
Telefax: 055639995974
E-Mail: abebooks@aha-buch.de
USt-IdNr.: DE261904229
registered at Commercial register Amtsgerichtes Göttingen
Handelsregisternummer HRB 200691
Alternative dispute resolution:
The European Commission provides a platform for out-of-court online dispute resolution (ODR platform), which can be accessed under https://ec.europa.eu/odr.
We have been a member of the "FairCommerce" initiative since 25.05.2018.
For more information, see www.fair-commerce.de.
Right of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to AHA-BUCH GmbH, Einbeck, Germany, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.
Shipping terms
We ship your order after we received them
for articles on hand latest 24 hours,
for articles with overnight supply latest 48 hours.
In case we need to order an article from our supplier our dispatch time depends on the reception date of the articles, but the articles will be shipped on the same day.
Our goal is to send the ordered articles in the fastest, but also most efficient and secure way to our customers.